子宫肌瘤的管理
Management of Uterine Fibroids
摘要: 子宫肌瘤是孕龄期妇女最常见的良性肿瘤，肌瘤相关症状严重影响女性身心健康及生活质量。目前子宫肌瘤治疗主要包括药物治疗、子宫切除术、子宫肌瘤剔除术、子宫动脉栓塞术及射频消融等微创技术。治疗必须根据症状、肌瘤的大小和位置、年龄、患者保持生育能力或子宫的需求和愿望、治疗的可用性以及医师的经验进行个体化。
Abstract: Uterine fibroids are the most common benign tumors in women of pregnancy age, and fi-broid-related symptoms seriously affect women’s physical and mental health and quality of life. At present, the treatment of uterine fibroids mainly includes minimally invasive techniques such as drug therapy, hysterectomy, myomectomy, uterine artery embolization and radiofrequency abla-tion. Treatment must be individualized based on symptoms, size and location of fibroids, age, pa-tient’s needs and desires to preserve fertility or the uterus, availability of treatments, and physician experience.
文章引用：周晓莹, 贾海云, 赵龙, 王胜利. 子宫肌瘤的管理[J]. 临床医学进展, 2023, 13(2): 2817-2823. https://doi.org/10.12677/ACM.2023.132397

参考文献

[1] 子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志, 2017, 52(12): 793-800.
[2] Wu, X.-J., Guo, Q., Cao, B.-S., et al. (2016) Uterine Leiomyomas: Safety and Efficacy of US-Guided Suprapubic Transvaginal Radiofrequency Ablation at 1-year Follow-up. Radiology, 279, 952-960. [Google Scholar] [CrossRef] [PubMed]
[3] Donnez, J. and Dolmans, M.M. (2016) Uterine Fibroid Manage-ment: From the Present to the Future. Human Reproduction Update, 22, 665-686. [Google Scholar] [CrossRef] [PubMed]
[4] 尚程辛. 子宫肌瘤家族聚集倾向相关研究[D]: [博士学位论文]. 北京: 北京协和医学院, 2014.
[5] Borah, B.J., Nicholson, W.K., Bradley, L., et al. (2013) The Impact of Uterine Leiomyomas: A National Survey of Affected Women. American Journal of Obstetrics and Gynecology, 209, 319.e1-319.e20. [Google Scholar] [CrossRef] [PubMed]
[6] Cardozo, E.R., Clark, A.D., Banks, N.K., et al. (2012) The Esti-mated Annual Cost of Uterine Leiomyomata in the United States. American Journal of Obstetrics and Gynecology, 206, 211.e1-211.e9. [Google Scholar] [CrossRef] [PubMed]
[7] Soliman, A.M., Yang, H., Du, E.X., et al. (2015) The Direct and Indirect Costs of Uterine Fibroid Tumors: A Systematic Review of the Literature between 2000 and 2013. American Journal of Obstetrics and Gynecology, 213, 141-160. [Google Scholar] [CrossRef] [PubMed]
[8] Rice, K.E., Secrist, J.R., Woodrow, E.L., et al. (2012) Etiology, Diagnosis, and Management of Uterine Leiomyomas. Journal of Midwifery & Women’s Health, 57, 241-247. [Google Scholar] [CrossRef] [PubMed]
[9] Petraglia, F., Serour, G.I. and Chapron, C. (2013) The Changing Prevalence of Infertility. International Journal of Gynaecology and Obstetrics, 123, S4-S8. [Google Scholar] [CrossRef] [PubMed]
[10] Wise, L.A., Palmer, J.R., Harlow, B.L., et al. (2004) Risk of Uter-ine Leiomyomata in Relation to Tobacco, Alcohol and Caffeine Consumption in the Black Women’s Health Study. Hu-man Reproduction, 19, 1746-1754. [Google Scholar] [CrossRef] [PubMed]
[11] Khan, A., Shehmar, M. and Gupta, J. (2014) Uterine Fibroids: Current Perspectives. International Journal of Women’s Health, 6, 95-114. [Google Scholar] [CrossRef] 
[12] 朱蒙蒙. 子宫内膜疾病与子宫肌瘤相关危险因素调查分析[D]: [硕士学位论文]. 长春: 吉林大学, 2016.
[13] Kim, J.J. and Sefton, E.C. (2012) The Role of Progesterone Signaling in the Pathogenesis of Uterine Leiomyoma. Molecular and Cellular Endocrinology, 358, 223-231. [Google Scholar] [CrossRef] [PubMed]
[14] Baird, D.D. and Dun-son, D.B. (2003) Why Is Parity Protective for Uterine Fibroids? Epidemiology, 14, 247-250. [Google Scholar] [CrossRef] 
[15] Munro, M.G., Critchley, H.O.D., Broder, M.S. and Fraser, I.S. (2011) FIGO Classification System (PALM-COEIN) for Causes of Abnormal Uterine Bleeding in Nongravid Women of Reproductive Age. International Journal of Gynecology & Obstetrics, 113, 3-13. [Google Scholar] [CrossRef] [PubMed]
[16] Vilos, G.A., Allaire, C., Laberge, P.Y., et al. (2015) The Manage-ment of Uterine Leiomyomas. Journal of Obstetrics and Gynaecology Canada, 37, 157-178. [Google Scholar] [CrossRef] 
[17] Dueholm, M., Lundorf, E., Hansen, E.S., Ledertoug, S. and Olesen, F. (2002) Accuracy of Magnetic Resonance Imaging and Transvaginal Ultrasonography in the Diagnosis, Map-ping, and Measurement of Uterine Myomas. American Journal of Obstetrics and Gynecology, 186, 409-415. [Google Scholar] [CrossRef] [PubMed]
[18] Chudnoff, S., Guido, R., Roy, K., et al. (2019) Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas. Obstetrics & Gynecology, 133, 13-22. [Google Scholar] [CrossRef] 
[19] 周应芳. 子宫肌瘤药物治疗之评价[J]. 实用妇产科杂志, 2016, 32(3): 180-182.
[20] De La Cruz, M.S. and Buchanan, E.M. (2017) Uterine Fibroids: Diagnosis and Treatment. American Family Physician, 95, 100-107.
[21] Lethaby, A., Vollenhoven, B. and Sowter, M. (2002) Efficacy of Pre-Operative Gonadotrophin Hormone Releasing Analogues for Women with Uterine Fibroids Undergoing Hysterec-tomy or Myomectomy: A Systematic Review. BJOG: An International Journal of Obstetrics & Gynaecology, 109, 1097-1108. [Google Scholar] [CrossRef] [PubMed]
[22] Falcone, T. and Walters, M.D. (2008) Hysterectomy for Benign Disease. Obstetrics & Gynecology, 111, 753-767. [Google Scholar] [CrossRef] 
[23] Kuppermann, M., Learman, L.A., Schembri, M., et al. (2010) Predictors of Hysterectomy Use and Satisfaction. Obstetrics & Gynecology, 115, 543-551. [Google Scholar] [CrossRef] 
[24] Farquhar, C.M., Sadler, L., Harvey, S.A. and Stewart, A.W. (2005) The Association of Hysterectomy and Menopause: A Prospective Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology, 112, 956-962. [Google Scholar] [CrossRef] [PubMed]
[25] Bräuner, E.V., Wilson, L.F., Koch, T., et al. (2022) The Long-Term Association between Bilateral Oophorectomy and Depression: A Prospective Cohort Study. Menopause, 29, 276-283. [Google Scholar] [CrossRef] 
[26] Uldbjerg, C.S., Wilson, L.F., Koch, T., et al. (2022) Oophorectomy and Rate of Dementia: A Prospective Cohort Study. Menopause, 29, 514-522. [Google Scholar] [CrossRef] 
[27] Thurston, J., Murji, A., Scattolon, S., et al. (2019) No. 377-Hysterectomy for Benign Gynaecologic Indications. Journal of Obstetrics and Gynaecology Canada, 41, 543-557. [Google Scholar] [CrossRef] [PubMed]
[28] 迟新红, 贾桂英. 阴式子宫肌瘤剥除术及腹腔镜下子宫肌瘤剥除术两种微创术式的效果观察[J]. 中国妇幼保健, 2014, 29(13): 2128-2129.
[29] Singh, S.S. and Belland, L. (2015) Contemporary Management of Uterine Fibroids: Focus on Emerging Medical Treatments. Current Medical Research and Opinion, 31, 1-12. [Google Scholar] [CrossRef] [PubMed]
[30] García, C.R. (1993) Management of the Symptomatic Fibroid in Women Older than 40 Years of Age. Hysterectomy or Myomectomy? Obstetrics and Gynecolo-gy Clinics of North America, 20, 337-348. [Google Scholar] [CrossRef] 
[31] Bérczi, V., Valcseva, É., Kozics, D., et al. (2015) Safety and Effectiveness of UFE in Fibroids Larger than 10 cm. Cardiovascular and Interventional Radiology, 38, 1152-1156. [Google Scholar] [CrossRef] [PubMed]
[32] Psilopatis, I., Fleckenstein, F.N., Collettini, F., et al. (2022) Short- and Long-Term Evaluation of Disease-Specific Symptoms and Quality of Life Following Uterine Artery Embolization of Fibroids. Insights Into Imaging, 13, Article No. 106. [Google Scholar] [CrossRef] [PubMed]
[33] Gupta, J.K., Sinha, A., Lumsden, M.A. and Hickey, M. (2014) Uterine Artery Embolization for Symptomatic Uterine Fibroids. The Cochrane Database of Systematic Reviews, No. 12, Article ID: CD005073. [Google Scholar] [CrossRef] 
[34] Yin, G., Chen, M., Yang, S., et al. (2015) Treatment of Uterine Myomas by Radiofrequency Thermal Ablation: A 10-Year Retrospective Cohort Study. Reproductive Sciences, 22, 609-614. [Google Scholar] [CrossRef] [PubMed]
[35] Havryliuk, Y., Setton, R., Carlow, J.J. and Shaktman, B.D. (2017) Symptomatic Fibroid Management: Systematic Review of the Literature. JSLS: Journal of the Society of Laparoendo-scopic Surgeons, 21, e2017.00041. [Google Scholar] [CrossRef] 
[36] Bradley, L.D., Pasic, R.P. and Miller, L.E. (2019) Clinical Perfor-mance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospec-tive Studies. Journal of Laparoendoscopic & Advanced Surgical Techniques, 29, 1507-1517. [Google Scholar] [CrossRef] [PubMed]
[37] Iversen, H. and Dueholm, M. (2017) Radiofrequency Thermal Ablation for Uterine Myomas: Long-Term Clinical Outcomes and Reinterventions. Journal of Minimally Invasive Gynecology, 24, 1020-1028. [Google Scholar] [CrossRef] [PubMed]
[38] Rey, V.E., Labrador, R., Falcon, M. and Garcia-Benitez, J.L. (2019) Transvaginal Radiofrequency Ablation of Myomas: Technique, Outcomes, and Complications. Journal of Laparoendo-scopic & Advanced Surgical Techniques, 29, 24-28. [Google Scholar] [CrossRef] [PubMed]
[39] 伦锦. 超声引导下射频消融治疗子宫肌瘤168例疗效观察[J]. 现代中西医结合杂志, 2012, 21(20): 2232-2233.
[40] Berman, J.M., Shashoua, A., Olson, C., Brucker, S., Thiel, J.A. and Bhagavath, B. (2020) Case Series of Reproductive Outcomes after Laparoscopic Radiofrequency Ablation of Sympto-matic Myomas. Journal of Minimally Invasive Gynecology, 27, 639-645. [Google Scholar] [CrossRef] [PubMed]

为你推荐